---
name: HCI-Baylor College of Medicine
abbreviation: HCI-BCM
logo: img/providers/HCI-BCM.png
---

The National Cancer Institute (NCI) launched the PDX (patient-derived xenografts) Development and Trial Centers Research Network (PDXNet) in September, 2017 to accelerate translational research using PDX datasets. The PDXNet comprises of four PDX Development and Trial Centers (PDTCs) and the PDX Data Commons and Coordinating Center (PDCCC).

The HCI-Baylor College of Medicine Patient-derived Xenograft Development and Trials Center(PDTC) is a multi-institutional Center comprising three well-established research groups: two from the Huntsman Cancer Institute (HCI) at the University of Utah, and one from Baylor College of Medicine (BCM). The HCI-BCM PDTC focuses on breast cancer, with 76 patient-derived xenografts (PDX) lines immediately available for Supplement proposals. [... Read more](https://www.pdxnetwork.org/hcibcm)
